We want to learn more about Shigella, a common bacterial cause of diarrhea worldwide. Knowledge from this study may be helpful in developing Shigella vaccines in the future.
Adults 18 to 50 years old in generally good health.
This study involves health screening, one study vaccine shot, admission to our extended stay research unit up to 10 days about a month after the study vaccine shot, complete several follow-up visits and phone calls.
Here are some of the things that will happen in this study:
You will:
During the stay in the extended stay research unit, study staff will be available at all times to care for you.
Adults interested in participating in this study will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered.
There is no direct benefit to you for participating in this study. However, when we complete the study, we hope to know more about Shigella infections which may be helpful in developing future Shigella vaccines.
Possible risks and discomforts will be discussed with those interested in learning more about the study.
Participants may receive up to $4770 to complete the study over approximately 7 months.
Gamble Program for Clinical Studies
513-636-7699
gamble.program@cchmc.org
Infectious Diseases
Cincinnati Children’s Hospital Medical Center
3333 Burnet Ave.
Cincinnati, OH 45229-3039
Robert Frenck
Infectious Diseases
Cincinnati Children’s Hospital Medical Center